explore -WSS

explore

author：explore 2025-10-03 00:06:42 - browse：37781

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Four alarming medical procedures we’re glad history forgot

hotspot

WSS

ActiGraph execs on goal of drug approvals with digital endpoints

Ukraine taking heavy casualties 10 weeks into its counteroffensive

New definition of a human embryo proposed amid rapid advances

Four alarming medical procedures we’re glad history forgot

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Bird flu reported in person exposed to presumably infected cattle

Wikipedia

explore

entertainment

At least 13 dead in Texas as scorching temps continue

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Psychedelics group wrestles with new pharma identity

ProMED sees offers of support, but its future remains unclear

Psychedelics group wrestles with new pharma identity

Study: Black kids more likely to die after surgery than white kids

Cancer drug shortages should be causing more outrage

Study: Black kids more likely to die after surgery than white kids

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA approves first treatment for ultra

leisure time

Young boy dies in trial for Pfizer Duchenne gene therapy

Mass General Brigham physicians react to latest merger step

Harvard scientists, with Google, unveil the most detailed brain map ever

Living with Hashimoto's and celiac disease, and med school, too

Four alarming medical procedures we’re glad history forgot

FDA approves first treatment for ultra

explore

hotspot

explore

knowledge